Cognitive functions, epileptic syndromes and antiepileptic drugs

Detalhes bibliográficos
Autor(a) principal: Bittencourt,Paulo R. M.
Data de Publicação: 1992
Outros Autores: Mader,Maria Joana, Bigarella,Monica M., Dóro,Maribel P., Gorz,Ana M., Marcourakis,Tania M., Ferreira,Zulma S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1992000100005
Resumo: Cognitive function of patients on monotherapy specific for their epileptic syndrome has been studied infrequently. We evaluated 7 patients with symptomatic localised epilepsies (SEL) on phenytoin aged 30±12 (mean±standard deviation) years, 8 with idiopathic generalised epilepsies on sodium valproate aged 18±4 years, 16 with SEL on carbamazepine aged 28±11 years, and 35 healthy controls aged 27±11 years. All subjects were of normal intelligence, educated appropriately to age, and led productive lives in the community. Two of the patients on carbamazepine and one on valproate had less than five partial, absence or myoclonic seizures monthly, the remaining were controlled. Carbamazepine serum concentrations were 12±5 ug/ml, phenytoin were 23±7, and valproate were 62±23 (mean±sd). Tests included immediate recall and recognition for pictures, Stroop test, delayed recall and recognition of pictures. Patients on phenytoin and valproate performed significantly worse than controls on immediate recall, and patients on carbamazepine performed significantly worse than controls in Stroop test (p<0,01). The results indicate relatively minor effects of the epileptic syndromes and of phenytoin, carbamazepine and valproate on cognition of patients with controlled epilepsy leading productive lives in the community. We conclude that the cognitive deficit found in chronic epileptic patients on polytherapeutic drug regimen must be multifactorial, and that future studies need to control for all possible variables in order to achieve meaningul results.
id ABNEURO-1_036ed3bcb31fba13e365339ab6e5d863
oai_identifier_str oai:scielo:S0004-282X1992000100005
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Cognitive functions, epileptic syndromes and antiepileptic drugsepilepsycognitive disordersneuropsychologyphenytoincarbamazepinesodium valproateCognitive function of patients on monotherapy specific for their epileptic syndrome has been studied infrequently. We evaluated 7 patients with symptomatic localised epilepsies (SEL) on phenytoin aged 30±12 (mean±standard deviation) years, 8 with idiopathic generalised epilepsies on sodium valproate aged 18±4 years, 16 with SEL on carbamazepine aged 28±11 years, and 35 healthy controls aged 27±11 years. All subjects were of normal intelligence, educated appropriately to age, and led productive lives in the community. Two of the patients on carbamazepine and one on valproate had less than five partial, absence or myoclonic seizures monthly, the remaining were controlled. Carbamazepine serum concentrations were 12±5 ug/ml, phenytoin were 23±7, and valproate were 62±23 (mean±sd). Tests included immediate recall and recognition for pictures, Stroop test, delayed recall and recognition of pictures. Patients on phenytoin and valproate performed significantly worse than controls on immediate recall, and patients on carbamazepine performed significantly worse than controls in Stroop test (p<0,01). The results indicate relatively minor effects of the epileptic syndromes and of phenytoin, carbamazepine and valproate on cognition of patients with controlled epilepsy leading productive lives in the community. We conclude that the cognitive deficit found in chronic epileptic patients on polytherapeutic drug regimen must be multifactorial, and that future studies need to control for all possible variables in order to achieve meaningul results.Academia Brasileira de Neurologia - ABNEURO1992-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1992000100005Arquivos de Neuro-Psiquiatria v.50 n.1 1992reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/S0004-282X1992000100005info:eu-repo/semantics/openAccessBittencourt,Paulo R. M.Mader,Maria JoanaBigarella,Monica M.Dóro,Maribel P.Gorz,Ana M.Marcourakis,Tania M.Ferreira,Zulma S.eng2011-02-22T00:00:00Zoai:scielo:S0004-282X1992000100005Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2011-02-22T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Cognitive functions, epileptic syndromes and antiepileptic drugs
title Cognitive functions, epileptic syndromes and antiepileptic drugs
spellingShingle Cognitive functions, epileptic syndromes and antiepileptic drugs
Bittencourt,Paulo R. M.
epilepsy
cognitive disorders
neuropsychology
phenytoin
carbamazepine
sodium valproate
title_short Cognitive functions, epileptic syndromes and antiepileptic drugs
title_full Cognitive functions, epileptic syndromes and antiepileptic drugs
title_fullStr Cognitive functions, epileptic syndromes and antiepileptic drugs
title_full_unstemmed Cognitive functions, epileptic syndromes and antiepileptic drugs
title_sort Cognitive functions, epileptic syndromes and antiepileptic drugs
author Bittencourt,Paulo R. M.
author_facet Bittencourt,Paulo R. M.
Mader,Maria Joana
Bigarella,Monica M.
Dóro,Maribel P.
Gorz,Ana M.
Marcourakis,Tania M.
Ferreira,Zulma S.
author_role author
author2 Mader,Maria Joana
Bigarella,Monica M.
Dóro,Maribel P.
Gorz,Ana M.
Marcourakis,Tania M.
Ferreira,Zulma S.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bittencourt,Paulo R. M.
Mader,Maria Joana
Bigarella,Monica M.
Dóro,Maribel P.
Gorz,Ana M.
Marcourakis,Tania M.
Ferreira,Zulma S.
dc.subject.por.fl_str_mv epilepsy
cognitive disorders
neuropsychology
phenytoin
carbamazepine
sodium valproate
topic epilepsy
cognitive disorders
neuropsychology
phenytoin
carbamazepine
sodium valproate
description Cognitive function of patients on monotherapy specific for their epileptic syndrome has been studied infrequently. We evaluated 7 patients with symptomatic localised epilepsies (SEL) on phenytoin aged 30±12 (mean±standard deviation) years, 8 with idiopathic generalised epilepsies on sodium valproate aged 18±4 years, 16 with SEL on carbamazepine aged 28±11 years, and 35 healthy controls aged 27±11 years. All subjects were of normal intelligence, educated appropriately to age, and led productive lives in the community. Two of the patients on carbamazepine and one on valproate had less than five partial, absence or myoclonic seizures monthly, the remaining were controlled. Carbamazepine serum concentrations were 12±5 ug/ml, phenytoin were 23±7, and valproate were 62±23 (mean±sd). Tests included immediate recall and recognition for pictures, Stroop test, delayed recall and recognition of pictures. Patients on phenytoin and valproate performed significantly worse than controls on immediate recall, and patients on carbamazepine performed significantly worse than controls in Stroop test (p<0,01). The results indicate relatively minor effects of the epileptic syndromes and of phenytoin, carbamazepine and valproate on cognition of patients with controlled epilepsy leading productive lives in the community. We conclude that the cognitive deficit found in chronic epileptic patients on polytherapeutic drug regimen must be multifactorial, and that future studies need to control for all possible variables in order to achieve meaningul results.
publishDate 1992
dc.date.none.fl_str_mv 1992-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1992000100005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1992000100005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-282X1992000100005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.50 n.1 1992
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212747805982720